Australian clinical-stage drug development company Noxopharm (ASX:NOX) has completed a $23 million share placement to professional, institutional, and sophisticated investors. …
Latest Video
New Stories
-
Medicines Australia appoints new senior policy executive
April 15, 2025 - - Latest News -
ViiV Healthcare announces the recipients of 2024 Positive Action Community Grants
April 15, 2025 - - Latest News -
US FDA announces plan to phase-out animal testing in drug development
April 15, 2025 - - Latest News -
This could be a path forward, a move to delay, or both, and we've seen it before
April 14, 2025 - - Latest News -
API launches new B2B e-commerce platform to support its more than 4,000 customers
April 14, 2025 - - Latest News -
Sorry minister, but there's no world in which you kept this election commitment to newborns
April 14, 2025 - - Latest News -
Pharmac to fund Novo Nordisk's long-acting insulin therapy
April 14, 2025 - - Latest News